Gencove Raises $10 Million to Meet the Global Demand for Accessible and Interpretable Whole Genome Sequencing at Scale
/PRNewswire/ -- Gencove, the leading low-pass genome sequencing platform company, today announced the successful close of a $10 million Series A investment...
Source: prnewswire.com